Try our Advanced Search for more refined results
May 30, 2018
Securities and Exchange Commission v. Curative Biosciences, Inc. et al
Case Number:
8:18-cv-00925
Court:
Nature of Suit:
Judge:
Firms
Companies
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 12, 2020
Jury Finds CBD Co. Liable In SEC's $4M Illicit Stock Sale Suit
A California federal jury sided with the U.S. Securities and Exchange Commission in its suit accusing a hemp company and its executives of pocketing $4 million in proceeds from the unregistered sale of more than 33 million shares of the company's stock, the SEC announced Thursday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login